|
|
| In-vitro Diagnostics--Industry Impact |
|
| Published : 2005/09 |
| End-user skepticism regarding the reliability of new assays for in-vitro diagnostics can be remedied with effective demonstrations and customer education about their remarkable benefits. ... |
| Opportunities for Proteomics Technology Markets in Europe |
|
| Published : 2005/09 |
| Proteomic research may incur huge capital investment and yield poor revenues for many commercial firms suggesting that there is a required wait period to cross the chasm as in the market lifecycle to see any foreseeable profits. With this uncertainty in t ... |
| Protein Microarrays: Technology Adoption & Utilization |
|
| Published : 2005/09 |
| As protein arrays have become more consistent and reliable, scientists have begun to incorporate them into their proteomics experiments. The technology's ability to detect protein expression more quickly and easily than traditional approaches has begun to ... |
| U.S. Genetic Diagnostics Markets |
|
| Published : 2005/09 |
| The increased understanding of the genetic basis of disease and genotype/phenotype correlation has allowed genetic diagnostics to become one of the fastest growing segments in the healthcare industry. However, there are challenges surrounding reimbursemen ... |
| AMGEN: Profile, Patents, and Pipeline |
|
| Published : 2005/08 |
| Amgen is the world's largest biotechnology company and the eighth largest pharmaceutical company worldwide. Revenues have nearly doubled in the last three years, going from $5.52 billion in 2002 to $10.55 billion in 2004. ... |
| Dynamic Antibody Industry |
|
| Published : 2005/08 |
| Monoclonal antibody drugs offer several advantages over other types of drugs. Technologically, antibodies exhibit amazing specificity that allows for a safe and targeted attack on disease-causing cells or compounds. ... |
| European Acute Cardiac Diagnostics Market |
|
| Published : 2005/08 |
| Manufacturers are responsible for educating end-users of their products by training the company's sales representatives and field specialists within the clinical setting or recruiting medical professionals, such as cardiologists and clinical technicians. ... |
| Progress in RNA-Based Therapeutics |
|
| Published : 2005/08 |
| The field of nucleic acid-based therapeutics ranges from gene therapy technologies for replacing defective or missing genes to gene-blocking or gene-silencing technologies for preventing the expression of deleterious genes. ... |
| The Top 10 Biotechnology Companies |
|
| Published : 2005/08 |
| This report provides a detailed analysis of the 10 leading biotechnology companies and how they are planning to sustain growth over the next five years ... |
| Nutrigenomics: Impacts on Markets, Diets, and Health |
|
| Published : 2005/07 |
| This report provides the scientific and business communities with an overview of what nutrigenomics?the tailoring of diet to personal genetics?currently is and what it might be in the future. ... |
| Pharmacodiagnostics: Technologies, Competition, & Market Models |
|
| Published : 2005/07 |
| Pharmacodiagnostics: Technologies, Competition, and Market Models examines the reasons why the business environment of pharmaceuticals is changing in favor of pharmacodiagnostics, and describes market models that are likely to emerge as the pharmaceutical ... |
| Probiotics: Ingredients, Supplements, Foods |
|
| Published : 2005/07 |
| The report covers probiotics as ingredients as well as probiotic applications for supplements and foods. It identifies a number of factors that have shaped historic trends in sales revenues and those that are projected to contribute to future trends in t ... |
| Strategic Analysis of the World Biogenerics Market |
|
| Published : 2005/07 |
| While the development of an abbreviated regulatory pathway is crucial to the approval of new biogenerics, growing concerns about the lack of a definition for bioequivalence and increasing pressure from major biotechnology companies anxious to defend their ... |
| THE WORLD BIOTECH MARKET REPORT 2005 |
|
| Published : 2005/07 |
| The biopharmaceutical market has expanded rapidly. No longer is it confined to growth hormones, insulin and red blood cell stimulating agents. Innovative science is accelerating the market into targeting a huge range of diseases from growth deficiency to ... |
| Biochips in Drug Discovery in Europe |
|
| Published : 2005/06 |
| Biochip technology has revolutionised and added a new dimension to the field of drug discovery. Biochips employed in tandem, with improved bioinformatics techniques and high throughput screening has enabled a dramatic increase in sample throughput in targ ... |
| Biopharmaceutical Developments--An Emerging Technology Analysis |
|
| Published : 2005/06 |
| This Technical Insights study provides an overview of the advances made by emerging technologies in biopharmaceuticals. The study includes detailed analyses of monoclonal antibodies, hormones and enzymes, cytokines and peptide therapeutics, vaccines and a ... |
| High-Growth Diagnostic Tests Markets |
|
| Published : 2005/06 |
| There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. ... |
| Strategic Analysis of the World Computational Biology Markets |
|
| Published : 2005/06 |
| Although computational biology tools have been around for a long time, their adoption is still in its initial stage. Pharmaceutical companies that have invested heavily in these tools have yet to see any tangible returns and are naturally skeptical about ... |
| U.S and Western European Bone Graft Substitute Market |
|
| Published : 2005/06 |
| The U.S. and Western European Bone Graft report is presented as a Microsoft Powerpoint presentation (>180 slides) and contains more than 100 figures and tables that are ideal for marketing purposes. ... |
|
|
Top
View Cart